Paige Secures Additional $15M from Goldman Sachs, for a Total Series B Funding Round of $70M
Amount Raised
$15 Million
Round Type
series b
Description
Paige, a global leader in computational pathology, today announced it received an additional $15M from Goldman Sachs Merchant Banking Division, totaling $20M from the firm. The funding will be added to previously announced Series B financing, bringing the total round to $70M, including an additional investment from Healthcare Venture Partners of $5M on top of their previous $10M investment. The funding brings the Company’s total capital raised to over $95M. Paige will use this new capital to further accelerate its global leadership position in transforming pathology workflows in the field of cancer, while working closely with biopharma companies to create custom diagnostic and clinical trial solutions to improve patient care.
FundzWatch™ Score
Buyer Intent Analysis
Get personalized insights on buying likelihood